Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Pricey Plug Power Stock Could Keep Moving Higher, or Attract a Buyer

By Tezcan Gecgil, InvestorPlace Contributor
Potential investors may regard the declines in PLUG stock as opportunity to go long Plug Power shares

The Case for Caution with DiamondPeak Stock

By Vince Martin, InvestorPlace Contributor
DiamondPeak stock is recovering after a pullback, and is up 160% since its merger was announced. But DPHC is far from a slam dunk.

Without Sales or a Real Target Market, Electrameccanica Stock Is a Big Gamble

By Chris Markoch, InvestorPlace Contributor
Electrameccanica Vehicles is launching its Solo car, but without a real market there's not enough reason to buy SOLO stock.

Pinterest Looks Overvalued, But That Might Not Prevent It From Rising

By Mark R. Hake, CFA
Pinterest looks overvalued here but it could still rise. Momentum plays like PINS stock peter out when they're over 200x earnings.

Why You Can Trust the Switchback Energy Acquisition SPAC to Deliver

By Josh Enomoto, InvestorPlace Contributor
This year may as well be the year of the SPAC, which includes EV charging station investment SBE stock. But diving into the details, this is one reverse merger to believe in.

AMD Stock Is So Richly Valued It Can Be a Currency To Buy Other Companies

By Mark R. Hake, CFA
AMD is so highly valued it can be a currency to buy other companies. AMD stock will end up with a lower overall P/E ratio if it uses its stock as currency for a lower P/E stock like Xilinx.

Rite Aid Stock Isn’t all that RAD

By Todd Shriber, InvestorPlace Contributor
Rite Aid and friends could easily be exceptions to that trend. Price action in PBM equities this year is, arguably, pricing in not only a victory by former Vice President Joe Biden, but the Democrats controlling both houses of Congress come January 2021. That would make it easy for the party to attack the issue of high drug prices, making RAD stock and rivals vulnerable in the process.

OXY Stock Looks Like a Hold as Oil Has Few Tailwinds

By Alex Sirois, InvestorPlace Contributor
OXY stock is a questionable equity for investors right now. Before you sell or buy, read why it's best to hold steady now.

5G Opportunity: Apple Finally Hops on the 5G Bandwagon

By Louis Navellier, Editor, Growth Investor
Apple will sell 50 million 5G iPhones this year alone, making it the second biggest 5G phone vendor. Next year, it should overtake the top slot. Clearly, there is a lot of opportunity here.

Don’t Give Up on Sorrento Therapeutics Stock Just Yet

By Ian Cooper, InvestorPlace Contributor
While Sorrento Therapeutics has an impressive pipeline, it needs to bring something to market. The clock is ticking on SRNE stock.

Recent IPO American Well Stock Is a Buy on Any Pullback

By InvestorPlace Research Staff
After its IPO, telemedicine play American Well stock has been hot. Ignore the takeover rumors and wait to buy AMWL on any pullback.

3 Reasons to Inject Your Portfolio with Sorrento Therapeutics

By InvestorPlace Research Staff
With the novel coronavirus becoming an extended reality for us, no one platform offers a comprehensive solution. And that’s why Sorrento Therapeutics’ all-in pivot bodes well for SRNE stock.

Can General Electric Really Come Out of Its Current Mess?

By Josh Enomoto, InvestorPlace Contributor
Jim Cramer of CNBC recently made some noise when he discussed the recovery narrative for GE stock. Though it’s an interesting argument, here’s why I’m skeptical.

Nokia Is Poised to Score After Setbacks

By Larry Sullivan, InvestorPlace contributor
Nokia stock isn’t getting the respect it deserves and the Finland-based company should get attention from value investors.

IBIO Remains a Purely Speculative Bet

By Faisal Humayun, InvestorPlace Contributor
IBIO stock is a purely speculative bet compared to better options when it comes to investing in Covid-19 vaccine development.

Interpace Biosciences News: Why IDXG Stock Is Soaring 48% Today

By William White, InvestorPlace Writer
Interpace Biosciences (IDXG) news for Wednesday includes a positive audit committee result giving IDXG stock a much-needed boost.

Investors Should Wait to Buy the Pullback in Snowflake

By Thomas Niel, InvestorPlace Contributor
The risk of competition, not a rich valuation, is the reason potential investors should continue skipping out on SNOW stock.

Social Capital Hedosophia II a Great Play on a Booming Housing Market

By InvestorPlace Research Staff
Via its pending merger with Opendoor, IPOB stock offers an attractive and high-tech way to play a U.S. housing market with several tailwinds.

If You Must Buy a Cannabis Stock, Canopy Growth Seems Like the One

By Chris Markoch, InvestorPlace Contributor
The U.S. government policy towards marijuana may be changing, but legalization still seems far away. Still, CGC stock may be worth the wait.
Load More Articles